< Back to previous page
Researcher
Rene Westhovens
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → Today
Projects
1 - 9 of 9
- The Future of Early Rheumatoid Arthritis Management: From Disease Control to Patient WellbeingFrom1 Oct 2018 → 31 Oct 2021Funding: FWO fellowships
- Spondyloarthritis in Kinshasa, DR Congo: Epidemiology, phenotype, immunogenetic, clinical diagnosis and management.From24 Jul 2018 → 24 Jul 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Validation of PROMIS item banks in Flemish patients with Rheumatoid Arthritis.From1 Nov 2017 → 31 Oct 2018Funding: Other federal public and semi-governmental institutions
- Unmet needs in early Rheumatoid Arthritis: lessons from the CareRA studyFrom1 Oct 2016 → 18 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Sensor-based Platform for the Accurate and Remote monitoring of Kine(ma)tics Linked to E-health (SPARKLE).From1 Oct 2014 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
- The impact of illness perceptions on health outcomes in patients with multisystem diseasesFrom1 Mar 2013 → 10 Nov 2017Funding: Other federal public and semi-governmental institutions
- TOWARDS IMPLEMENTATION OF INTENSIVE COMBINATION TREATMENT STRATEGIES FOR EARLY RHEUMATOID ARTHRITISFrom1 Oct 2011 → 31 Dec 2015Funding: Private funding of national origin - undefined
- Towards a better understanding of functioning in patients with axial spondyloarthritis: an application of the International Classification of Functioning, Disability and Health (ICF) modelFrom1 Nov 2010 → 28 Jun 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Transfer and transition of adolescents and young adults with juvenile idiopathic arthritisFrom1 Oct 2008 → 5 Jul 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 345
- Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well-Being and Disease Activity(2023)
Authors: Michaël Doumen, Diederik De Cock, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 758 - 767 - Filgotinib in rheumatoid arthritis(2023)
Authors: Rene Westhovens
Pages: 135 - 144 - Correspondence on 'EULAR recommendations for a core data set for pregnancy registries in rheumatology'(2023)
Authors: Diederik De Cock, Delphine Bertrand, Veerle Stouten, Rene Westhovens, Patrick Verschueren
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update(2023)
Authors: Patrick Verschueren, Rene Westhovens
Pages: 3 - 18 - Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial(2023)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 39 - 45 - Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial(2022)
Authors: Delphine Bertrand, Diederik De Cock, Michaël Doumen, Rene Westhovens, Patrick Verschueren
Pages: 470 - 480 - Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
- Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020)(2022)
Authors: Paul De Munter, Bénédicte Dubois, Rene Westhovens
- Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes(2022)
Authors: Rene Westhovens
- Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis(2022)
Authors: Patrick Verschueren, Rene Westhovens
Pages: 937 - 943